申联生物：2025年净亏损1909.07万元

Group 1 - The core point of the article is that Shenlian Biological has reported a decline in revenue and a net loss for the fiscal year 2025, although the loss has decreased compared to the previous year [1] Group 2 - The company achieved an operating income of 288 million yuan, representing a year-on-year decrease of 4.99% [1] - The net profit attributable to shareholders was a loss of 19.09 million yuan, which is a reduction in loss by 57.33% year-on-year [1] - The basic earnings per share were -0.05 yuan, showing an increase of 54.55% compared to the previous year [1]